E339D (p.Glu339Asp) variant of GCK (Hexokinase-4)

E339D (p.Glu339Asp) in GCK (Hexokinase-4) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Monogenic diabetes. The available variant effect predictions contribute to a CATVariant prioritization score of 0.79 / 1. The record also includes published literature and structural context.

E339D (p.Glu339Asp) variant details